JCHO Hokkaido Hospital

Sapporo, Hokkaido 062-8618

0 studies enrolling now · 5 studies all time

What they study most

Metabolic Dysfunction-Associated SteatoHepatitis (MASH), NASH, Nonalcoholic Steatohepatitis, Ulcerative Colitis

Studies at this site

• A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition — Recruiting now
• ABTECT - Maintenance — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis — Completed
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed